Low-Dose Yellow Fever Vaccine in Adults in Africa

Cheruiyot, Stanley; Kimathi, Derick; Ndeye, BobS.

dc.contributor.author	Cheruiyot, Stanley
dc.contributor.author	Kimathi, Derick
dc.contributor.author	Ndeye, BobS.
dc.date.accessioned	2025-02-26T12:19:28Z
dc.date.available	2025-02-26T12:19:28Z
dc.date.issued	2025-02
dc.identifier.uri	http://ir.mu.ac.ke:8080/jspui/handle/123456789/9584
dc.description.abstract	Yellow fever vaccine is highly effective with a single dose, but vaccine supply is limited. The minimum dose requirements for seroconversion remain unknown.	en_US
dc.language.iso	en	en_US
dc.publisher	The New Journal of England Medicine	en_US
dc.subject	Yellow fever	en_US
dc.subject	Vaccine	en_US
dc.title	Low-Dose Yellow Fever Vaccine in Adults in Africa	en_US
dc.title.alternative	Ph.D., Benedict Orindi, Ph.D., Maria L. Namulwana, M.B., Ch.B., Antoine Diatta, Pharm.D., t, B.Sc.	en_US
dc.type	Article	en_US